TY - JOUR
T1 - Clinical manifestations and risk factors of Streptococcus suis mortality among Northern Thai population
T2 - Retrospective 13-year cohort study
AU - Rayanakorn, Ajaree
AU - Katip, Wasan
AU - Goh, Bey Hing
AU - Oberdorfer, Peninnah
AU - Lee, Learn Han
N1 - Funding Information:
We would like to thank the staff at Chiang Mai University Hospital, Boonchira Kitisith, Ekkachai Jongkire, Areerat Kittikunakorn of the Office of Medical Records and Statistics, Wilai Baosoung, Paduangkiat Kamnoi of CMUH Microbiology Laboratory for their kind support in data access and facilitating our 6-month data collection, Donsuk Pongnikorn and Weerawat Chanla of Lampang Cancer Hospital for the introduction and guidance regarding case record form (CRF) use and design, Shaun Lee of School of Pharmacy, Monash University Malaysia for his advice on statistical analysis. The work was financially supported by Monash Global Asia in the 21st Century (GA21) research grant (GA-HW-19-L01 & GA-HW-19-S01) and Fundamental Research Grant Scheme (FRGS/1/2019/ WAB09/MUSM/02/1& FRGS/1/2019/SKK08/MUSM/02/7).
Funding Information:
The study was approved by the Research Ethics Committee, Faculty of Medicine, Chiang Mai University (IRB no.010/2018) and Monash University Human Research Ethics Committee (MUHREC) (Project no.12225). Patient names, personal and other traceable information that could be used to identify the person were omitted and treated as confidential in all processes of data collection and management.
Publisher Copyright:
© 2019 Rayanakorn et al.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2019/12/30
Y1 - 2019/12/30
N2 - Purpose: Streptococcus suis (S. suis) is an emerging zoonotic disease mainly in pigs, causing serious infections in humans with high prevalence in Southeast Asia. Despite a relatively high mortality rate, there are limited data regarding the risk factors of this life-threatening infection. Therefore, a 13-year retrospective cohort study in Chiang Mai, Thailand during 2005–2018 was conducted to explore risk factors associated with S. suis mortality and to update the outcomes of the disease. Patients and methods: S. suis positive cases were derived from those with positive S. suis isolates from microbiological culture results and Matrix-Assisted Laser Desorption Ionization Time of Flight (MALDI-TOF). Potential risk factors of mortality were identified using univariate and multivariate logistic regression. Results: Of 133 patients with culture-proven S. suis infection identified, there were 92 males and 41 females. The mean age was 56.47 years. Septicemia (55.64%) was the most common clinical manifestation followed by meningitis (37.59%) and infective endocarditis (25.56%). Alcohol drinking and raw pork consumption were documented in 66 (49.62%) and 49 (36.84%) cases respectively. The overall mortality rate was 12.03% (n=16). According to the multivariate analysis, the independent risk factors for mortality were prolonged bacteremia ≥ 6 days (OR = 43.57, 95% CI = 2.46–772.80, P =0.010), septic shock (OR = 13.34, 95% CI = 1.63–109.03, P =0.016), and direct bilirubin > 1.5 mg/dL (OR = 12.86, 95% CI = 1.91–86.59, P =0.009). Conclusion: S. suis is not infrequent in Northern Thailand, where the cultural food habit of raw pork eating is still practiced. To the best of our knowledge, this is the largest series focusing on risk factors of S. suis mortality which has been conducted in Thailand. Prolonged bacteremia ≥ 6 days, septic shock, and direct bilirubin > 1.5 mg/dL were strong predictors associated with S. suis mortality. The mortality risk factors identified may be further utilized in clinical practice and future research to improve patient outcomes.
AB - Purpose: Streptococcus suis (S. suis) is an emerging zoonotic disease mainly in pigs, causing serious infections in humans with high prevalence in Southeast Asia. Despite a relatively high mortality rate, there are limited data regarding the risk factors of this life-threatening infection. Therefore, a 13-year retrospective cohort study in Chiang Mai, Thailand during 2005–2018 was conducted to explore risk factors associated with S. suis mortality and to update the outcomes of the disease. Patients and methods: S. suis positive cases were derived from those with positive S. suis isolates from microbiological culture results and Matrix-Assisted Laser Desorption Ionization Time of Flight (MALDI-TOF). Potential risk factors of mortality were identified using univariate and multivariate logistic regression. Results: Of 133 patients with culture-proven S. suis infection identified, there were 92 males and 41 females. The mean age was 56.47 years. Septicemia (55.64%) was the most common clinical manifestation followed by meningitis (37.59%) and infective endocarditis (25.56%). Alcohol drinking and raw pork consumption were documented in 66 (49.62%) and 49 (36.84%) cases respectively. The overall mortality rate was 12.03% (n=16). According to the multivariate analysis, the independent risk factors for mortality were prolonged bacteremia ≥ 6 days (OR = 43.57, 95% CI = 2.46–772.80, P =0.010), septic shock (OR = 13.34, 95% CI = 1.63–109.03, P =0.016), and direct bilirubin > 1.5 mg/dL (OR = 12.86, 95% CI = 1.91–86.59, P =0.009). Conclusion: S. suis is not infrequent in Northern Thailand, where the cultural food habit of raw pork eating is still practiced. To the best of our knowledge, this is the largest series focusing on risk factors of S. suis mortality which has been conducted in Thailand. Prolonged bacteremia ≥ 6 days, septic shock, and direct bilirubin > 1.5 mg/dL were strong predictors associated with S. suis mortality. The mortality risk factors identified may be further utilized in clinical practice and future research to improve patient outcomes.
KW - Mortality
KW - Risk factor
KW - S. suis
KW - S. suis infection
KW - Streptococcus suis
KW - Thailand
UR - http://www.scopus.com/inward/record.url?scp=85077877622&partnerID=8YFLogxK
U2 - 10.2147/IDR.S233326
DO - 10.2147/IDR.S233326
M3 - Article
C2 - 32021313
AN - SCOPUS:85077877622
SN - 1178-6973
VL - 12
SP - 3955
EP - 3965
JO - Infection and Drug Resistance
JF - Infection and Drug Resistance
ER -